Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

Yazar: Escudier, Bernard, Cosaert, Jan, Jethwa, Sangeeta
Baskı/Yayın Bilgisi 2008

Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC

Yazar: Gerber, David E., Swanson, Paul, Lopez-Chavez, Ariel, Wong, Lucas, Dowlati, Afshin, Pennell, Nathan A., Cronier, Damien M., Qin, Amy, Ilaria, Robert, Cosaert, Jan, Shahir, Ashwin, Baggstrom, Maria Q.
Yayımlandı Lung Cancer (2017)

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

Yazar: LoRusso, Patricia M., Gounder, Mrinal, Jalal, Shadia I., André, Valérie, Kambhampati, Siva Rama Prasad, Loizos, Nick, Hall, Jennifer, Holzer, Timothy R., Nasir, Aejaz, Cosaert, Jan, Kauh, John, Chiorean, E. Gabriela
Yayımlandı Invest New Drugs (2017)

A Phase 1 Study of Anti-TGFβ Receptor Type-II Monoclonal Antibody LY3022859 in Patients with Advanced Solid Tumors

Yazar: Tolcher, Anthony W., Berlin, Jordan D., Cosaert, Jan, Kauh, John, Chan, Emily, Piha-Paul, Sarina A., Amaya, Alex, Tang, Shande, Driscoll, Kyla, Kimbung, Richard, Prasad Kambhampati, S. R., Gueorguieva, Ivelina, Hong, David S.
Yayımlandı Cancer Chemother Pharmacol (2017)

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

Yazar: Gradishar, William J., Yardley, Denise A., Layman, Rachel, Sparano, Joseph A., Chuang, Ellen, Northfelt, Donald W., Schwartz, Gary N., Youssoufian, Hagop, Tang, Shande, Novosiadly, Ruslan, Forest, Amelie, Nguyen, Tuan S., Cosaert, Jan, Grebennik, Dmitri, Haluska, Paul
Yayımlandı Clin Cancer Res (2015)

An Open-label, Dose-Escalation Phase 1 Study of anti-TYRP1 monoclonal antibody IMC-20D7S for patients with relapsed or refractory melanoma

Yazar: Khalil, Danny N., Postow, Michael A., Ibrahim, Nageatte, Ludwig, Dale L., Cosaert, Jan, Kambhampati, Siva Rama Prasad, Tang, Shande, Grebennik, Dmitri, Kauh, John Sae Wook, Lenz, Heinz-Josef, Flaherty, Keith T., Hodi, F. Stephen, Lawrence, Donald P., Wolchok, Jedd D.
Yayımlandı Clin Cancer Res (2016)

Olaratumab and doxorubicin versus doxorubicin alone in soft tissue sarcoma

Yazar: Tap, William D., Jones, Robin L., Van Tine, Brian A., Chmielowski, Bartosz, Elias, Anthony D., Adkins, Douglas, Agulnik, Mark, Cooney, Matthew M., Livingston, Michael B., Pennock, Gregory, Hameed, Meera R., Shah, Gaurav D., Qin, Amy, Shahir, Ashwin, Cronier, Damien M., Ilaria, Robert, Conti, Ilaria, Cosaert, Jan, Schwartz, Gary K.
Yayımlandı Lancet (2016)